DANNY PERLAZA: Open Payments
NPI 1669115754 · MINEOLA, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$170 in 7 payments from 7 companies in 2025. Trend: 2023 $99 · 2024 $151 · 2025 $170
Food & beverage: $170
| Company | Payments | Amount |
|---|---|---|
| Astellas Pharma US Inc | 1 | $31 |
| BeOne Medicines USA, Inc. | 1 | $30 |
| GENZYME CORPORATION | 1 | $27 |
| Daiichi Sankyo Inc. | 1 | $25 |
| TAIHO ONCOLOGY, INC. | 1 | $21 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $18 |
| Celgene Corporation | 1 | $18 |
Products named: Cresemba, BRUKINSA, SARCLISA, Vanflyta, LONSURF, Nubeqa, REBLOZYL.
Industry payments across NY — which companies pay providers there.
